Clinical trials

A Venezuelan migrant girl, wearing a protective face mask with a graphic version of the Virgin of Guadalupe, waits for a bus to travel to the border, after breaking camp in Bogota, Colombia, Thursday, July 2, 2020. Facing no work due to the COVID-19-related economic shutdown, hundreds of Venezuelan migrants are returning to their country. (AP Photo/Fernando Vergara)
July 02, 2020 - 10:56 pm
SEOUL, South Korea -- South Korea has reported 63 newly confirmed cases of COVID-19 as health authorities scramble to mobilize public health tools to the southwestern city of Gwangju, where more than 50 people were found sickened over the past week. The figures announced by the Korea Centers for...
Read More
People protest against Coronavirus trials in Africa, outside the University of the Witwatersrand in Johannesburg, South Africa, Wednesday, July 1, 2020. A protest against Africa’s first COVID-19 vaccine trial is underway as experts note a worrying level of resistance and misinformation around testing on the continent. (AP Photo/Themba Hadebe)
July 01, 2020 - 12:47 pm
JOHANNESBURG (AP) — Protesters against Africa’s first COVID-19 vaccine trial burned their face masks Wednesday as experts note a worrying level of resistance and misinformation around testing on the continent. Anti-vaccine sentiment in Africa is “the worst I’ve ever seen,” the CEO of the GAVI...
Read More
A vaccine volunteer gets an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg Wednesday, June 24, 2020. Africa’s first participation in a COVID-19 vaccine trial has begun as volunteers received injections developed at the University of Oxford in Britain. The large-scale trial is being conducted in South Africa, Britain and Brazil. (AP Photo/Siphiwe Sibeko)
June 24, 2020 - 9:49 am
JOHANNESBURG (AP) — Africa's first participation in a COVID-19 vaccine trial started Wednesday as volunteers received injections developed at the University of Oxford in Britain, while officials said the continent of 1.3 billion people cannot be left behind. The large-scale trial is being conducted...
Read More
June 17, 2020 - 12:04 pm
MOSCOW (AP) — Clinical trials of a Russian coronavirus vaccine have started Wednesday, the Health Ministry said in a statement. Two forms of the vaccine developed by the Moscow-based Gamaleya research institute — liquid and powder for injections — will be tested on two groups of volunteers, 38...
Read More
French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France, Tuesday, June 16, 2020.The visit comes after rival pharmaceutical company AstraZeneca this weekend announced a deal to supply 400 million vaccine doses to EU countries, including France. (AP Photo/Laurent Cipriani, Pool)
June 16, 2020 - 8:11 am
LONDON (AP) — Scientists at Imperial College London will start immunizing people in Britain this week with their experimental coronavirus shot, while pharmaceutical company Sanofi and the French government announced more than 800 million euros ($890 million) in investment Tuesday as part of the...
Read More
People walk along a popular street, in Ankara, Turkey, Wednesday, June 3, 2020, days after the government lifted a series of restrictions imposed to fight the coronavirus pandemic. People crowded popular streets and parks while restaurants and cafes welcomed sit-in customers and beaches and museums reopened as part of Turkey's broadest easing of coronavirus restrictions. (AP Photo/Burhan Ozbilici)
June 03, 2020 - 3:01 pm
ANKARA, Turkey (AP) — Turkey and Russia have agreed to cooperate in the development of a coronavirus vaccine and plan to carry out joint clinical trials, the Turkish health minister said Wednesday. Health Minister Fahrettin Koca said scientific advisers from the two countries were scheduled to hold...
Read More
May 25, 2020 - 8:35 pm
CANBERRA, Australia (AP) — A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia on Tuesday with hopes of releasing a proven vaccine this year. Novavax will inject 131 volunteers in the first phase of the trial testing the safety of the vaccine and...
Read More
FILE - This Tuesday, April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. The World Health Organization said Monday May 25, 2020, that it will temporarily drop hydroxychloroquine from its global study into experimental COVID-19 treatments because its experts need to review all available evidence. (AP Photo/David J. Phillip, File)
May 25, 2020 - 1:46 pm
GENEVA (AP) — The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial drug U.S. President Trump says he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to...
Read More
Dominic Cummings, senior aide to Prime Minister Boris Johnson, makes a statement inside 10 Downing Street, London, Monday May 25, 2020, over allegations he breached coronavirus lockdown restrictions. (Jonathan Brady/Pool via AP)
May 25, 2020 - 12:31 pm
The Latest on the coronavirus pandemic. The new coronavirus causes mild or moderate symptoms for most people. For some, especially older adults and people with existing health problems, it can cause more severe illness or death. TOP OF THE HOUR: — World Health Organization said that it will...
Read More
A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020. President Donald Trump’s declaration that he was taking the antimalarial drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating cases of the coronavirus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for COVID-19. (AP Photo/Rafiq Maqbool)
May 19, 2020 - 8:50 pm
NEW DELHI (AP) — President Donald Trump’s declaration that he was taking a malaria drug of dubious effectiveness to help fend off the coronavirus will likely be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring...
Read More

Pages